c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation - PubMed (original) (raw)
. 1994 Dec;9(12):3499-508.
Affiliations
- PMID: 7970710
c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation
S A La Rocca et al. Oncogene. 1994 Dec.
Abstract
The c-Myc oncoprotein is a basic-helix-loop-helix-leucine zipper (b-HLH-LZ) transcription factor involved in regulating cell proliferation and differentiation. We have used retrovirus-mediated gene transfer to investigate the effect of ectopic c-Myc expression on the spontaneous differentiation of primary quail myoblasts in vitro. Unlike normal myoblasts, c-Myc-expressing myoblasts are unable to form myotubes or express muscle-specific genes, such as myosin, and show severely reduced expression of the myogenic regulatory factors myoD, myogenin, and myf5. The c-Myc leucine zipper (LZ) motif is essential for the differentiation block since myoblasts expressing a mutant with a partial deletion of this region, c-Myc delta 7, differentiate and express myoD family regulators and muscle-specific genes normally. Remarkably, c-Myc delta 7, like wild-type c-Myc, retains the capacity to transform the growth phenotype of myoblasts, and associates with the b-HLH-LZ Myc partner protein Max in transformed cells. We conclude that the block to myogenic differentiation induced by c-Myc can be dissociated from cell transformation per se, and that this attribute correlates more closely with down-regulation of myoD family gene expression. These findings are discussed in the light of current models of Myc function.
Similar articles
- Selective repression of myoD transcription by v-Myc prevents terminal differentiation of quail embryo myoblasts transformed by the MC29 strain of avian myelocytomatosis virus.
La Rocca SA, Vannucchi S, Pompili M, Pinney DF, Emerson CP Jr, Grossi M, Tatò F. La Rocca SA, et al. Oncogene. 2002 Jul 18;21(31):4838-42. doi: 10.1038/sj.onc.1205586. Oncogene. 2002. PMID: 12101422 - Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
Valdez MR, Richardson JA, Klein WH, Olson EN. Valdez MR, et al. Dev Biol. 2000 Mar 15;219(2):287-98. doi: 10.1006/dbio.2000.9621. Dev Biol. 2000. PMID: 10694423 - The molecular basis of skeletal muscle differentiation.
Dias P, Dilling M, Houghton P. Dias P, et al. Semin Diagn Pathol. 1994 Feb;11(1):3-14. Semin Diagn Pathol. 1994. PMID: 8202645 Review. - C-MYC: evidence for multiple regulatory functions.
Penn LJ, Laufer EM, Land H. Penn LJ, et al. Semin Cancer Biol. 1990 Feb;1(1):69-80. Semin Cancer Biol. 1990. PMID: 2133113 Review.
Cited by
- c-Myc-dependent transcriptional regulation of cell cycle and nucleosomal histones during oligodendrocyte differentiation.
Magri L, Gacias M, Wu M, Swiss VA, Janssen WG, Casaccia P. Magri L, et al. Neuroscience. 2014 Sep 12;276:72-86. doi: 10.1016/j.neuroscience.2014.01.051. Epub 2014 Feb 4. Neuroscience. 2014. PMID: 24502923 Free PMC article. - Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc.
Dai MS, Jin Y, Gallegos JR, Lu H. Dai MS, et al. Neoplasia. 2006 Aug;8(8):630-44. doi: 10.1593/neo.06334. Neoplasia. 2006. PMID: 16925946 Free PMC article. Review. - Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation.
Marampon F, Ciccarelli C, Zani BM. Marampon F, et al. Int J Mol Sci. 2019 May 23;20(10):2530. doi: 10.3390/ijms20102530. Int J Mol Sci. 2019. PMID: 31126017 Free PMC article. Review. - Cell divisions are not essential for the direct conversion of fibroblasts into neuronal cells.
Fishman VS, Shnayder TA, Orishchenko KE, Bader M, Alenina N, Serov OL. Fishman VS, et al. Cell Cycle. 2015;14(8):1188-96. doi: 10.1080/15384101.2015.1012875. Cell Cycle. 2015. PMID: 25695848 Free PMC article. - v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
Clark W, Black EJ, MacLaren A, Kruse U, LaThangue N, Vogt PK, Gillespie DA. Clark W, et al. Mol Cell Biol. 2000 Apr;20(7):2529-42. doi: 10.1128/MCB.20.7.2529-2542.2000. Mol Cell Biol. 2000. PMID: 10713176 Free PMC article.